GBS

(Group B Streptococcus)

GBS continues to be a leading cause of early-onset neonatal sepsis, prompting the need for earlier and more precise detection. Fast and accurate PCR testing with the GeneXpert® system provides standardised, on-demand, and actionable results for better patient management. That’s the PCRplus advantage.

Challenge

Increased Threat to Newborns Due to Inaccurate Antepartum or Risk-Based GBS Screening

Solution

Fast & Accurate Intrapartum PCR Testing for GBS in as soon as 30 Minutes^*

Learn More

* For positive GBS results with Early Assay Termination (EAT). 42 minutes for negative GBS results.

^ IAP: Intrapartum Antibiotic Prophylaxis, EOD: Early Onset Disease, AMR: Antimicrobial Resistance

1 Helmig R, et al. Diagnostic accuracy of polymerase chain reaction for intrapartum detection of group B streptococcus colonization. Acta Obstet Gynecol Scand. 2017 Sep;96(9):1070-1074.

2 Di Renzo G, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med. 2015 May;28(7):766-82.

3 Björklund V, et al. Replacing risk-based early-onset-disease prevention with intrapartum group B streptococcus PCR testing. J Matern Fetal Neonatal Med. 2017 Feb;30(3):368-373.

4 Picchiassi E, et al. Intrapartum test for detection of Group B Streptococcus colonization during labor. J Matern Fetal Neonatal Med. 2018 Dec;31(24):3293-330.

CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.